We are live on
!
Find out more
ARC
Absolute Return Capital Portfolio holdings
AUM
$1.57B
1-Year Est. Return
6.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
-6.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.1B
AUM Growth
+$1.89B
(+26%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
12.63%
Holding
786
New
160
Increased
244
Reduced
271
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$145M |
| 2 |
Procter & Gamble
PG
|
+$121M |
| 3 |
Chevron
CVX
|
+$104M |
| 4 |
Apple
AAPL
|
+$95.7M |
| 5 |
Microsoft
MSFT
|
+$74.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$52.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$50.3M |
| 3 |
Pfizer
PFE
|
+$42.9M |
| 4 |
CNX Resources
CNX
|
+$42.5M |
| 5 |
CVS Health
CVS
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.5% |
| 2 | Energy | 14.11% |
| 3 | Healthcare | 12.44% |
| 4 | Technology | 10.58% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
National Fuel Gas
NFG
$7.89B
| $7.43M | 0.08% |
104,125
-52,941
| -34% | -$3.68M |
|
|
NVO
277
Novo Nordisk
NVO
$215B
| $7.42M | 0.08% |
401,350
| – | – |
|
278
Revvity
RVTY
$12.5B
| $7.36M | 0.08% |
178,547
-43,231
| -19% | -$1.65M |
|
279
NiSource
NI
$22.4B
| $7.36M | 0.08% |
569,462
+77,949
| +16% | +$966K |
|
|
BRLI
280
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $7.32M | 0.08% |
286,739
+216,235
| +307% | +$6.66M |
|
281
Bristol-Myers Squibb
BMY
$126B
| $7.3M | 0.08% |
137,358
-485,141
| -78% | -$24.7M |
|
282
Conagra Brands
CAG
$6.92B
| $7.3M | 0.08% |
278,336
+135,152
| +94% | +$3.38M |
|
283
Titan International
TWI
$499M
| $7.28M | 0.08% |
404,904
| – | – |
|
284
Ross Stores
ROST
$75.2B
| $7.28M | 0.08% |
194,180
+12,722
| +7% | +$478K |
|
|
BMR
285
DELISTED
BIOMED REALTY TRUST INC
BMR
| $7.21M | 0.08% |
398,162
-30,947
| -7% | -$587K |
|
|
CMA
286
DELISTED
Comerica
CMA
| $7.1M | 0.08% |
149,385
-8,144
| -5% | -$358K |
|
|
BNY
287
Bank of New York Mellon
BNY
$109B
| $7.09M | 0.08% |
202,827
+41,148
| +25% | +$1.34M |
|
|
BEAV
288
DELISTED
B/E Aerospace Inc
BEAV
| $7.07M | 0.08% |
112,166
+44,752
| +66% | +$2.67M |
|
289
Geospace Technologies
GEOS
$90.7M
| $7.03M | 0.08% |
74,322
+7,101
| +11% | +$653K |
|
|
WCG
290
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.97M | 0.08% |
99,035
+27,946
| +39% | +$1.95M |
|
|
PDM
291
Piedmont Realty Trust
PDM
$1.19B
| $6.86M | 0.08% |
415,072
-16,943
| -4% | -$293K |
|
|
SE
292
DELISTED
Spectra Energy Corp Wi
SE
| $6.82M | 0.08% |
+191,400
| New | +$6.59M |
|
293
Graco
GGG
$12.7B
| $6.81M | 0.07% |
261,657
+112,740
| +76% | +$2.88M |
|
294
Agnico Eagle Mines
AEM
$71.7B
| $6.66M | 0.07% |
252,605
| – | – |
|
295
Visa
V
$666B
| $6.66M | 0.07% |
+119,708
| New | +$6.04M |
|
296
PRA Group
PRAA
$618M
| $6.6M | 0.07% |
124,968
+4,474
| +4% | +$254K |
|
297
Marvell Technology
MRVL
$187B
| $6.54M | 0.07% |
455,125
+50,808
| +13% | +$654K |
|
|
MFA
298
MFA Financial
MFA
$924M
| $6.53M | 0.07% |
231,156
-76,313
| -25% | -$2.23M |
|
299
Patterson-UTI
PTEN
$4.01B
| $6.35M | 0.07% |
250,763
-98,135
| -28% | -$2.35M |
|
|
INXN
300
DELISTED
Interxion Holding N.V.
INXN
| $6.32M | 0.07% |
267,802
| – | – |
|
Similar funds
OA
MCC
NM
AH
TRV
GHF
CWA
RI
Absolute Return Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Absolute Return Capital held 786 positions worth $9.1B, up 26% from $7.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Absolute Return Capital deployed $1.21B of net new capital in Q4 2013, opening 160 new positions and adding to 244 existing holdings. Its largest new stake was Apple: 5,068,168 shares worth $102M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $52.3M trimmed.
- Absolute Return Capital's largest Q4 2013 buy was Apple: 5,068,168 shares worth $102M.
- Absolute Return Capital added most to ExxonMobil in Q4 2013, an estimated $145M increase.
- Absolute Return Capital's biggest Q4 2013 reduction was Amgen, cutting an estimated $52.3M.
- Absolute Return Capital fully exited Johnson & Johnson in Q4 2013, selling an estimated $50.3M.
- Absolute Return Capital's ten largest holdings make up 13% of its $9.1B portfolio in Q4 2013.
- Absolute Return Capital opened 160 new positions and closed 99 in Q4 2013.
- Absolute Return Capital's portfolio value rose 26% quarter-over-quarter to $9.1B.
Based on Absolute Return Capital's 13F filing for Q4 2013, filed 10 Feb 2014.